IDEXX Laboratories, Inc. vs Merck & Company, Inc. — Stock Comparison
IDEXX Laboratories, Inc. (IDXX) and Merck & Company, Inc. (MRK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
IDEXX Laboratories, Inc. scores ahead of Merck & Company, Inc. on Q·Score (7.8 vs 6.4 out of 10), led by Quality (9.3 vs 4.9) and Growth (7.9 vs 6.4). Merck & Company, Inc. scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst consensus targets imply greater upside for IDXX (+36.8%) than for MRK (+6.4%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 74% return on equity and 25% profit margins.
71% of 28 covering analysts have a positive rating.
⚠ weak profitability metrics drag quality score.
Analyst Consensus
Fundamentals
Frequently Asked Questions
IDXX vs MRK: which stock scores better overall?
Based on Q·Score, IDEXX Laboratories, Inc. (IDXX) scores 7.8/10 versus Merck & Company, Inc. (MRK) at 6.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: IDXX or MRK?
IDEXX Laboratories, Inc. (IDXX) scores higher on Growth (7.9/10 vs 6.4/10). IDEXX Laboratories, Inc. reports revenue growth (9.7% YoY) while Merck & Company, Inc. reports (5.1% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is IDXX or MRK more attractively valued?
IDEXX Laboratories, Inc. (IDXX) scores higher on Valuation (7.9/10 vs 7/10). IDXX trades at 30.5× P/E versus MRK at 15.1×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about IDXX vs MRK?
There are 13 analysts covering IDXX with a consensus price target of $698.92, and 26 analysts covering MRK with a consensus target of $152.96. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: IDXX or MRK?
IDEXX Laboratories, Inc. (IDXX) scores higher on Quality (9.3/10 vs 4.9/10). Net profit margin: IDXX at 25.0%, MRK at 4.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: IDXX or MRK?
IDEXX Laboratories, Inc. (IDXX) scores higher on Financial Health (7/10 vs 7/10). Market beta: IDXX at 1.54, MRK at 0.23. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of IDXX and MRK?
IDEXX Laboratories, Inc. (IDXX) has a market capitalisation of $40.2B, while Merck & Company, Inc. (MRK) has a market cap of $354.8B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do IDXX or MRK pay dividends?
IDXX does not currently pay a dividend, while MRK pays a dividend yield of 2.35%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →